Protocol 4: Post-menopausal metabolic restoration Goal: Address menopausal weight gain and metabolic changes Stack: Tirzepatide: Standard protocol (addresses insulin resistance) Tesamorelin: 1-2mg daily (visceral fat) CJC-1295/Ipamorelin: 200mcg each before bed (body composition, bone density) Resistance training: 3-4x per week Adequate protein and calcium Duration: 12+ months, potentially ongoing Expected results: 25-45 pounds weight loss Reduced visceral fat Improved insulin sensitivity Better body composition Maintained bone density Why this works: Addresses multiple menopausal factors - insulin resistance, visceral fat, muscle loss, bone density
All current data derive from clinical trial settings, and its use outside of approved trials is not sanctioned
The effect of body mass index change on cholelithiasis after laparoscopic sleeve gastrectomy
Nat Immunol (2010) 11:37384
These results suggest that GPX4 is essential for maintaining normal metabolic activity during ferroptosis in mice
The next morning, the S-Trap was centrifuged at 4,000 g for 1 min to collect the digested peptides